Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases-1 and-2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C. Comparison using ROC analysis

Digestive Diseases and Sciences

Volumn 44, Issue 3, 1999, Pages 624-630

  Walsh, Kevin Michael ^a,b   Timms, Peter ^a,b   Campbell, Stewart ^a,b   MacSween, Ronald Norman MacIver ^a,b   Morris, Allan John ^a,b,c  

^a NHS Greater Glasgow and Clyde Clinical Biochemistry Service   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Hepatitis C; Liver biopsy; Matrix metalloproteinase 2; Metalloproteinase inhibitors; Noninvasive marker; ROC analysis

Indexed keywords

GELATINASE A; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME ANALYSIS; FEMALE; HEPATITIS C; HUMAN; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

EID: 0033020765     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026630129025     Document Type: Article

References (30)

1. 1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A non-B viral hepatitis-genome. Science 244:359-362, 1989
2. 2. Esumi M, Shikata T: Hepatitis C virus and liver diseases. Pathol Int 44:85-95, 1994
3. 3. Mansell CJ, Locarnini SA: Epidemiology of hepatitis C in the East. Semin Liver Dis 15:15-32, 1995
4. 4. Simmonds P, Zhang LQ, Watson HG, Rebus S, Ferguson ED, Balfe P, Leadbetter GH, Yap PL, Peithere JL, Ludlam CA: Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug abusers. Lancet 336:1469-1472, 1990
5. 5. Aledort LM, Levine PH, Hilgartner M, Blatt P, Spero JA, Goldberg JD, Bianchi L, Desmet V, Scheuer P, Popper H, Berk PD: A study of liver biopsies and liver disease among haemophiliacs. Blood 66:367-372, 1985
6. 6. Tong MJ, el-Farra NS, Reikes AR, Co RL: Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332:1463-1466, 1995
7. 7. McCormick SE, Goodman ZD, Maydonovitch CL, Sjogren MH: Evaluation of liver histology, ALT elevation, and HCV RNA titer in patients with chronic hepatitis C. Am J Gastroenterol 91:1516-1522, 1996
8. 8. Haber MM, West AB, Haber AD, Reuben A: Relationship of aminotransferases to liver histological status in chronic hepatitis C. Am J Gastroenterol 90:1250-1257, 1995
9. 9. Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, Nevens F, Solinas A, Realdi G: Morbidity and mortality in compensated cirrhosis type C. Gastroenterology 112:463-472, 1997
10. 10. Arthur MJP: Degradation of matrix proteins in liver fibrosis. Pathol Res Pract 190:825-833, 1994
11. 11. Benyon RC, Iredale JP, Goddard S, Winwood PJ, Arthur MJP: Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology 110:821-831, 1996
12. 12. Milani S, Herbst H, Schuppan D, Grappone C, Pellegrini G, Pinzani M, Casini A, Calabro A, Ciancio G, Stefanini F, Burroughs AK, Surrenti C: Differential expression of matrix metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am J Pathol 144:528-537, 1994
13. 13. Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T: Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. J Immunol Methods 127:103-108, 1990
14. 14. Fujimoto N, Zhang J, Iwata K, Shinya T, Okada Y, Hayakawa T: A one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases-2 using monoclonal antibodies. Clin Chim Acta 220:31-45, 1993
15. 15. Fujimoto N, Mouri N, Iwata K, Ohuchi E, Okada Y, Hayakawa T: A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 using monoclonal antibodies. Clin Chim Acta 221:91-103, 1993
16. 16. Plumpton TA, Clark IM, Plumpton C, Calvin J, Cawston TE: Development of an enzyme-linked immunosorbent assay to measure total TIMP-1 and measurement of TIMP 1 and CRP in serum. Clin Chim Acta 240:137-154, 1994
17. 17. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Kork G, MacSween RN, Thaler H: Histological staging and grading of chronic hepatitis. J Hepatol 22:696-699, 1995
18. 18. Beck JR, Shultz EK: The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med 110:13-20, 1986
19. 19. Vida S: A computer program for non-parametric receiver operating characteristic analysis. Comput Methods Programs Biomed 40:95-101, 1993
20. 20. Fleiss JL: Statistical Methods for Rates and Proportions. New York, John Wiley, 1988, pp 14, 28-29
21. 21. Cawston TE: Proteinase inhibitors of metalloproteinases. In Proteinase Inhibitors. AJ Barrett, G Salvesen (eds). Amsterdam, Elsevier, 1986, pp 589-610
22. 22. Li J, Rosman AS, Leo MA, Nagai Y, Lieber CS: Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis. Hepatology 19:1418-1423, 1994
23. 23. Murawaki Y, Yamamoto H, Kawasaki H, Shima H: Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and hepatocellular carcinoma. Clin Chim Acta 218:47-58, 1993
24. 24. Muzzillo DA, Imoto M, Fukuda Y, Koyama Y, Saga S, Nagai Y, Hayakawa T: Clinical evaluation of serum tissue inhibitor of metalloproteinases-1 levels in patients with liver diseases. J Gastroenterol Hepatol 8:437-441, 1993
25. 25. Ueno T, Tamaki S, Sugawara H, Inuzuka S, Torimura T, Sata M, Tanikawa K: Significance of serum tissue inhibitor of metalloproteinases-1 in various liver diseases. J Hepatol 24:177-184, 1996
26. 26. Murawaki Y, Ikuta Y, Idobe Y, Kitamura Y, Kawasaki H: Tissue inhibitor of metalloproteinase-1 in the liver of patients with chronic liver disease. J Hepatol 26:1213-1219, 1997
27. 27. Wong VS, Wight DGD, Palmer CR, Alexander GJM: Fibrosis and other histological features in chronic hepatitis C virus infection: A statistical model. J Clin Pathol 49:465-469, 1996
28. 28. Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT, Liotta LA: Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 265:13933-13938, 1990
29. 29. Ebata M, Fukuda Y, Nakano I, Katano Y, Fujimuto N, Hayakawa T: Serum levels of tissue inhibitor of metalloproteinases-2 and of precursor form of matrix metalloproteinase-2 in patients with liver disease. Liver 17:293-299, 1997
30. 30. Kasahara A, Hayashi N, Mochizuki K, Oshita M, Katayama K, Kato M, Masuzawa M, Yoshihara H, Naito M, Miyamoto T, Inoue A, Asai A, Hijioka T, Fusamoto H, Kamada T: Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. J Hepatol 26:574-583, 1997